- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 202.62M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.46B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.46B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $7M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $7M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $130M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $125M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.27B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.28B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.98B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.95B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.25B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.19B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.28B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.28B |
| Dividends Paid | Q1 2025 · Jan 31, 2025 | $12M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 238.99M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $107M |
| Capex | Q1 2025 · Mar 31, 2024 | $32M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $84M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$735M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$735M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.28 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.28 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $64M |
| Net Income | Q1 2025 · Mar 31, 2024 | $66M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $172M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $743M |